## GWW: W.W. Grainger, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.3% below STRENGTH zone (4.0-10.0%); PEG 2.11 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($986.01)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Morgan Stanley | $1100 | $1150 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 9 ($0.15M) |
| Sells | 5 ($0.40M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (+1.9%)
- Blackrock Inc.: 8.6% (-0.4%)
- State Street Corpora: 4.2% (+0.7%)
- Geode Capital Manage: 2.5% (-4.2%)
- Wells Fargo & Compan: 2.1% (-3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.11 elevated, pricing in significant growth expectations. Forward P/E 23.4x stretched relative to 11% growth. Quality metrics strong (ROE 47%, ROA 19%). Balance sheet: strong liquidity (2.7x). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $49.0B |
| Beta | 1.12 |
| 52W Range | $893.99 - $1139.15 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.11 |
| Forward P/E | 23.4 |
| Current P/E | 25.9 |
| YoY Growth | 11.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 7.1% to 2.3% (-4.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.7pp (needs >4.0% for momentum thesis). MRS_5 (-1.7%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.4% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.77), confirming momentum. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.33% (CS: 77) | Neutral |
| RSI_14 | 63.2 | Neutral |
| MACD Histogram | 3.77 | Bullish |
| vs SMA20 | 1.034x | Above |
| vs SMA50 | 1.058x | Above |
| vs SMA200 | 1.022x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1023.41
- **Stop Loss:** $986.01 (3.7% risk)
- **Target:** $1060.81 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 24
- **Position Value:** $24,561.84
- **Portfolio %:** 24.56%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-03 (Est: $9.44)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.95 | $10.21 | +2.6% |
| 2025Q2 | $10.07 | $9.97 | -1.0% |
| 2025Q1 | $9.51 | $9.86 | +3.7% |
| 2024Q4 | $9.74 | $9.71 | -0.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*